$76.85
+0.02 (+0.03%)
Open$76.83
Previous Close$76.83
Day High$76.86
Day Low$76.80
52W High$77.20
52W Low$9.10
Volume—
Avg Volume3.59M
Market Cap1.57B
P/E Ratio—
EPS$-4.58
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
-89.6% upside
Current
$76.85
$76.85
Target
$7.97
$7.97
$5.39
$7.97 avg
$9.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 518.0K | 558.0K | 44.14M |
| Net Income | -96,508,269 | -93,566,133 | -12,888,213 |
| Profit Margin | -158,800.0% | -150,860.0% | -29.2% |
| EBITDA | -98,203,516 | -100,499,127 | -17,594,581 |
| Free Cash Flow | — | — | -11,802,396 |
| Rev Growth | -7.2% | -7.2% | -3.2% |
| Debt/Equity | — | — | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |